Vascular Therapies Overview
- Year Founded
-
2001
- Status
-
Out of Business
- Employees
-
7
- Latest Deal Type
-
Out of Business
Vascular Therapies General Information
Description
Operator of a biotech company intended to address major unmet clinical needs of patients requiring an AV fistula for dialysis. The company's therapies are used to offer biodegradable collagen implants to treat the problem of vascular anastomosis failure, enabling physicians to improve the outcomes of an arteriovenous fistula and improve patients' lives.
Contact Information
Website
www.vasculartx.comCorporate Office
- 105 Union Avenue
- Cresskill, NJ 07626
- United States
Corporate Office
- 105 Union Avenue
- Cresskill, NJ 07626
- United States
Vascular Therapies Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 11. Out of Business | 12-Nov-2025 | Completed | Out of Business | |||
| 10. Later Stage VC | 18-Feb-2022 | Completed | Clinical Trials - Phase 3 | |||
| 9. Later Stage VC | 28-Jan-2020 | Completed | Clinical Trials - Phase 3 | |||
| 8. Later Stage VC (Series E2) | 10-Oct-2018 | Completed | Clinical Trials - Phase 3 | |||
| 7. Later Stage VC (Series E) | 14-Dec-2016 | Completed | Clinical Trials - Phase 3 | |||
| 6. Later Stage VC (Series D) | 12-Jul-2013 | Completed | Clinical Trials - Phase 3 | |||
| 5. Later Stage VC | 01-Dec-2012 | Completed | Clinical Trials - Phase 3 | |||
| 4. Seed Round | 09-Jun-2011 | Completed | Clinical Trials - Phase 3 | |||
| 3. Grant | 01-Jan-2009 | $244K | $7.49M | Completed | Startup | |
| 2. Angel (individual) | 17-Oct-2005 | $7.49M | $7.49M | Completed | Startup |
Vascular Therapies Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series E2 | ||||||||
| Series E1 | ||||||||
| Series D | ||||||||
| Series C2 | ||||||||
| Series C1 | ||||||||
| Series B4 | ||||||||
| Series B3 | ||||||||
| Series B2 | ||||||||
| Series B1 | 169,000 | $0.001000 | 8% | $0.01 | $0.01 | 1x | $0.01 | 0.05% |
| Series A4 | 316,667 | $0.001000 | 8% | $3 | $3 | 1x | $3 | 0.99% |
Vascular Therapies Patents
Vascular Therapies Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| WO-2025250493-A1 | Product to treat or prevent stenosis in a blood vessel | Pending | 31-May-2024 | ||
| WO-2025250493-A9 | Product to treat or prevent stenosis in a blood vessel | Pending | 31-May-2024 | ||
| WO-2024119179-A1 | Unitary product for addressing arteriovenous fistula stenosis | Inactive | 03-Dec-2022 | ||
| JP-2019150584-A | Device and method for preventing constriction at anastomotic site | Pending | 27-Jan-2010 | ||
| EP-2528537-A1 | Device and method for preventing stenosis at an anastomosis site | Inactive | 27-Jan-2010 | A61F2/064 |
Vascular Therapies Signals
Vascular Therapies FAQs
-
When was Vascular Therapies founded?
Vascular Therapies was founded in 2001.
-
Where is Vascular Therapies headquartered?
Vascular Therapies is headquartered in Cresskill, NJ.
-
What is the size of Vascular Therapies?
Vascular Therapies has 7 total employees.
-
What industry is Vascular Therapies in?
Vascular Therapies’s primary industry is Therapeutic Devices.
-
Is Vascular Therapies a private or public company?
Vascular Therapies is a Private company.
-
What is Vascular Therapies’s current revenue?
The current revenue for Vascular Therapies is .
-
How much funding has Vascular Therapies raised over time?
Vascular Therapies has raised $112M.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process